NovoCure Ltd (NVCR) stock
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3033% below fair value
$10.73−0.41 (-3.68%)
Close on Nov 18, 2026Market cap $1.25BP/E –Yield –
NovoCure price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
NovoCure's price to book ratio was 4.1× on Nov 11, 2026, against 4.2× a year earlier. Over the last 5 years it ranged from 3.3× to 21.5×, with a median of 5.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.1× | −0.1 |
| 2025 | Dec 31, 2025 | 4.2× | −4.7 |
| 2024 | Dec 31, 2024 | 8.9× | +4.9 |
| 2023 | Dec 29, 2023 | 4.0× | −13.2 |
| 2022 | Dec 30, 2022 | 17.3× | −1.6 |
| 2021 | Dec 31, 2021 | 18.9× | −38.5 |
| 2020 | Dec 31, 2020 | 57.3× | +13.5 |
| 2019 | Dec 31, 2019 | 43.8× | +16.7 |
| 2018 | Dec 31, 2018 | 27.1× | +11.6 |
| 2017 | Dec 29, 2017 | 15.5× | +11.2 |
| 2016 | Dec 30, 2016 | 4.3× | +2.0 |
| 2015 | Dec 31, 2015 | 2.3× | – |
See a number that looks wrong?